picted in Figure 1). An attractive approach would consist of
direct interconnections of the heterocyclic subunits, mainly
thiazole, pyridine, and sometimes oxazole, using heteroaryl-
heteroaryl coupling reactions.
pharmaceutics. As a first example, a synthesis of the ethyl
saramycetate subunit of the cyclothiazomycin thiopeptide was
proposed.
Scheme 1. Study of Single-Step BSC Protocol for Introduction
of 2-Ketothiazol-4-yl Unit in Our Previously Reported tert-Butyl
Sulfomycinamate Thio-analogue 1 Synthesis
Figure 1. Three main common bi- or triazolylpyridine cores of d
series thiopeptide antibiotics.
Such a strategy was initially explored by Kelly some 20
years ago3a,b and remained largely unexplored until the recent
remarkable Bach synthesis of the GE2270A central core
based upon a three-step sequence of cross-coupling reactions
starting from 2,3,6-tribromopyridine, as reported in 2005.3c
In this context, we have recently reported a palladium-
catalyzed direct connection of the common oxazole and
thiazole-4-carboxylate blocks to a central pyridine unit, thus
avoiding the intermediary preparation of thiazolyl- or py-
ridinylmetals classically used in cross-coupling methodolo-
gies.4 The method was directly applied to a neat synthesis
of a tert-butyl sulfomycinamate thio-analogue through a
three-step direct arylation, chlorination, and Stille cross-
coupling sequence (Scheme 1). Following this work, we
focused on a novel friendly protocol for the direct introduc-
tion of the 2-ketothiazole unit at position-4 to the central
pyridine core. Indeed, the Stille cross-coupling methodology,
currently employed for this last connection, requires prior
preparation of the 4-stannyl intermediate 3 using a two-step
keto-protection, transmetalation-stannylation protocol4c fol-
lowed by a coupling step and a final hydrolysis as depicted
in Scheme 1. Herein we report the borylation Suzuki coupling
(BSC) of 4-bromo-2-ketothiazoles 4a,b with 2-halopyridines
to give direct access to 4-pyridinyl-2-ketothiazoles. These
are common features of the heterocyclic cores of thiopeptide
antibiotics. The methodology was directly applied to an
innovative synthesis of the tert-butyl sulfomycinamate thio-
analogue 1 and the micrococcinate 13 ester. The scope of
this novel BSC protocol for ketothiaozles 4a,b, using various
coupling partners, was also evaluated for the further synthesis
of 4-substituted 2-ketothiazole-based natural products and
The 4-bromo-2-ketothiazoles 4a,b were ready prepared in
high yield from the commercially available 2,4-dibromothia-
zole via regioselective lithium-bromide exchange and
quenching with N-acetyl and propionylmorpholines.5
A first set of palladium-catalyzed borylations of 4-bromo-
2-acetyl and propionylthiazoles 4a,b was carried out under
the Masuda and Baudoin processes using pinacolborane as
a cheaper borylating agent.6 In both cases, production of
borylated thiazoles was not observed. We then turned to
bis(pinacol)borane as employed by Miyaura,7g and we
decided to check the nature of the ligand as the main
borylation parameter using Pd2(dba)3 as recently suggested
by Buchwald,7a KOAc as base, and dioxane as solvent (Table
1).7 Except for the bidentate ligand dppf (entry 1), we were
pleased to observe that all Buchwald ligands, as well as the
carbene ligand IMes, allowed good conversion of the starting
material as measured by GC monitoring to give the expected
4-borylated thiazoles 8a,b in short reaction time (0.5-3 h).
We then immediately evaluated the performance of the
same catalyst systems that proved efficient in the prior
borylation reaction8 for a subsequent Suzuki coupling of
2-chloropyridine using the K3PO4 base, following the
(5) Gebauer, J.; Arseniyadis, S.; Cossy, J. Org. Lett. 2007, 9, 3425–
3427.
(6) For palladium-catalyzed borylation of aromatics methods using
pinacolborane, see: (a) Broutin, P.-E.; Cerna, I.; Campaniello, M.; Leroux,
F.; Colobert, F. Org. Lett. 2004, 6, 4419–4422. (b) Baudoin, O.; Gue´nard,
D.; Gue´ritte, F. J. Org. Chem. 2000, 65, 9268–9271. (c) Murata, M.;
Watanabe, S.; Masuda, Y. J. Org. Chem. 1997, 62, 6458–6459.
(7) For palladium-catalyzed borylation of aromatics methods using
bis(pinacol)borane, see: (a) Billingsley, K. L.; Barder, T. E.; Buchwald,
S. L. Angew. Chem., Int. Ed. 2007, 46, 5359–5363. (b) Zhu, L.; Duquette,
J.; Zhang, M. J. Org. Chem. 2003, 68, 3729–3732. (c) Fu¨rstner, A.; Seidel,
G. Org. Lett. 2002, 4, 541–543. (d) Ishiyama, T.; Ishida, K.; Miyaura, N.
Tetrahedron 2001, 57, 9813–9816. (e) Ishiyama, T.; Itoh, Y.; Kitano, T.;
Miyaura, N. Tetrahedron Lett. 1997, 38, 3447–3450. (f) Giroux, A.; Han,
Y.; Prasit, P. Tetrahedron Lett. 1997, 38, 3841–3844. (g) Ishiyama, T.;
Murata, M.; Miyaura, N. J. Org. Chem. 1995, 60, 7508–7510.
(8) Both borylated thiazoles 8a,b proved to be highly unstable under
usual isolating procedures.
(3) (a) Kelly, T. R.; Jagoe, C. T.; Gu, Z. Tetrahedron Lett. 1991, 32,
4263–4266. (b) Kelly, T. R.; Lang, F. J. Org. Chem. 1996, 61, 4623–4633.
(c) First synthesis of a heterocyclic core of a thiopeptide antibiotic
(GE2270A) in a complete cross-coupling approach: Heckmann, G.; Bach,
T. Angew. Chem., Int. Ed 2005, 44, 1199–1201.
(4) (a) Martin, T.; Verrier, C.; Hoarau, C.; Marsais, F. Org. Lett. 2008,
10, 2909–2912. (b) Verrier, C.; Martin, T.; Hoarau, C.; Marsais, F. J. Org.
Chem. 2008, 73, 7383–7386. (c) Direct palladium-catalyzed stannylation
of 4a using bistrimethystannane is penalized by the side production of 2,2′-
acetyl-4,4′-bithiazole (35% GC yield), which could not be isolated from
the expected 2-acetylthiazol-4-ylstannane (51% GC yield).
Org. Lett., Vol. 11, No. 16, 2009
3691